论文部分内容阅读
目前,术后辅助化疗对直肠黏液腺癌患者生存效果的影响仍不清楚,Chand M等人对在2000~2010年期间进行了TME手术的191例直肠黏液腺癌患者的5年生存率进行了研究,并应用Cox比例风险回归模型进行单变量和多变量分析。本组患者的平均龄64.6岁。结果发现,接受了辅助化疗的患者5年生存率是66.1%,未接受者是35.2%(P<0.0001)。该研究结
At present, the effect of postoperative adjuvant chemotherapy on survival in patients with rectal mucinous adenocarcinoma remains unclear. Chand M et al. Performed a five-year survival on 191 patients with rectal mucinous adenocarcinoma who underwent TME surgery between 2000 and 2010 Study, and Cox proportional hazards regression model for univariate and multivariate analysis. The average age of this group of patients 64.6 years old. The results showed that the 5-year survival rate of patients receiving adjuvant chemotherapy was 66.1%, 35.2% of non-recipients (P <0.0001). The study concluded